FRANKFURT--The following is a summary of analysts' forecasts for
GlaxoSmithKline plc (GSK) second-quarter results, based on a poll
of six analysts conducted by Dow Jones Newswires (figures in
million pound, EPS and target price in pence, according to IFRS).
Earnings figures are scheduled to be released July 23.
===
Core
Core Net
Turnover operat. Core attrib. Core
2nd Quarter total profit PBT profit EPS
AVERAGE 5,737 1,574 1,414 1,037 21.6
Prev. Year 6,373 1,878 1,702 1,230 25.3
+/- in % -10 -16 -17 -16 -15
MEDIAN 5,724 1,580 1,419 1,042 21.7
Maximum 5,828 1,596 1,436 1,050 21.8
Minimum 5,650 1,543 1,381 1,009 21.0
Amount (a) 6 6 5 5 6
Bernstein 5,828 1,596 1,429 1,050 21.8
Deutsche Bank 5,672 1,586 1,419 1,042 21.7
Exane BNP Paribas 5,672 1,543 1,381 1,009 21.0
Helvea 5,775 1,573 1,436 1,048 21.8
Kepler Cheuvreux 5,827 1,586 -- -- 21.7
Target price Rating
AVERAGE 1,668 positive 1
Prev. Quarter 1,625 neutral 4
+/- in % +2.7 negative 0
MEDIAN 1,650
Maximum 1,800
Minimum 1,600
Amount 6
Bernstein 1,650 Market perform
Deutsche Bank 1,630 Hold
Exane BNP Paribas 1,600 --
Helvea 1,680 Hold
Kepler Cheuvreux 1,800 Buy
Panmure Gordon 1,650 Hold
===
Year-earlier figures are as restated by the company.
(a) Including anonymous estimates from one more analyst.
DJG/voi
Subscribe to WSJ: http://online.wsj.com?mod=djnwires